Correlation Between Sangamo Therapeutics and Dermata Therapeutics
Can any of the company-specific risk be diversified away by investing in both Sangamo Therapeutics and Dermata Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sangamo Therapeutics and Dermata Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Sangamo Therapeutics and Dermata Therapeutics, you can compare the effects of market volatilities on Sangamo Therapeutics and Dermata Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sangamo Therapeutics with a short position of Dermata Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sangamo Therapeutics and Dermata Therapeutics.
Diversification Opportunities for Sangamo Therapeutics and Dermata Therapeutics
0.21 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Sangamo and Dermata is 0.21. Overlapping area represents the amount of risk that can be diversified away by holding Sangamo Therapeutics and Dermata Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Dermata Therapeutics and Sangamo Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sangamo Therapeutics are associated (or correlated) with Dermata Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Dermata Therapeutics has no effect on the direction of Sangamo Therapeutics i.e., Sangamo Therapeutics and Dermata Therapeutics go up and down completely randomly.
Pair Corralation between Sangamo Therapeutics and Dermata Therapeutics
Given the investment horizon of 90 days Sangamo Therapeutics is expected to under-perform the Dermata Therapeutics. In addition to that, Sangamo Therapeutics is 1.69 times more volatile than Dermata Therapeutics. It trades about -0.12 of its total potential returns per unit of risk. Dermata Therapeutics is currently generating about -0.01 per unit of volatility. If you would invest 134.00 in Dermata Therapeutics on December 29, 2024 and sell it today you would lose (16.00) from holding Dermata Therapeutics or give up 11.94% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Sangamo Therapeutics vs. Dermata Therapeutics
Performance |
Timeline |
Sangamo Therapeutics |
Dermata Therapeutics |
Sangamo Therapeutics and Dermata Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Sangamo Therapeutics and Dermata Therapeutics
The main advantage of trading using opposite Sangamo Therapeutics and Dermata Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sangamo Therapeutics position performs unexpectedly, Dermata Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Dermata Therapeutics will offset losses from the drop in Dermata Therapeutics' long position.Sangamo Therapeutics vs. Editas Medicine | Sangamo Therapeutics vs. Intellia Therapeutics | Sangamo Therapeutics vs. Bluebird bio | Sangamo Therapeutics vs. Alnylam Pharmaceuticals |
Dermata Therapeutics vs. Zura Bio Limited | Dermata Therapeutics vs. Phio Pharmaceuticals Corp | Dermata Therapeutics vs. Sonnet Biotherapeutics Holdings | Dermata Therapeutics vs. 180 Life Sciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
Other Complementary Tools
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio |